NasserHHannaMD

Oncology • Indianapolis, IN

Associate Professor, Medicine, Indiana University School of Medicine

Join to view full profile

Dr. Hanna is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hanna's full profile

Already have an account?

Office
535 Barnhill Dr
# ROUTE473
Indianapolis, IN 46202
Phone+1 317-278-0054

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1998 - 2000
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1995 - 1998
University of Missouri-Columbia School of MedicineClass of 1995

Certifications & Licensure

IN State Medical License 1999 - 2025
IA State Medical License 1995 - 1999
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Start of enrollment: 2006 Feb 23
Completed
Phase 2
Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Start of enrollment: 2002 Feb 01
Completed
Phase 3
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Start of enrollment: 2005 May 01
Completed
Phase 1, Phase 2
Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer Start of enrollment: 2005 Jan 01
Terminated
Phase 2
A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Completed
Phase 2
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas Start of enrollment: 2006 Apr 01
Completed
Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer Start of enrollment: 2006 Aug 01
Completed
Phase 2
Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer Start of enrollment: 2006 Oct 01
Completed
Phase 1, Phase 2
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer Start of enrollment: 2007 Jun 01
Terminated
Phase 1, Phase 2
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Completed
Phase 2
Sutent + Taxol for Advanced Esophageal Cancer Start of enrollment: 2008 Aug 01
Completed
Phase 2
Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer Start of enrollment: 2009 Jan 01
Terminated
Phase 2
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2010 Sep 21
Active, not recruiting
Phase 2
Telephone Support Program for Lung Cancer Patients and Their Family Caregivers Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

115 citations
Lung cancer screening: what do long‐term smokers know and believe?
Lisa Carter-Harris, Duy Khanh P. Ceppa, Nasser Hanna, Susan M. Rawl
Health Expectations. 2017-02-01
135 citations
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
Nasser H. Hanna, Rogerio Lilenbaum, Rafat Ansari, Thomas J. Lynch, Ramaswamy Govindan
Journal of Clinical Oncology. 2006-11-20
1949 citations
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, José Rodrigues Pereira, Filippo de Marinis
Journal of Clinical Oncology. 2004-05-01

Other

Adjuvant systemic therapy in resectable non-small cell lung cancer
Hanna N
http://www.uptodate.com/contents/adjuvant-systemic-therapy-in-resectable-non-small-cell-lung-cancer
UpToDate, Wolters Kluwer Health - 2013-03-25

Press Mentions

Honoring a Father’s Life and LegacyNovember 17th, 2022
Cancer Physician-Scientist Offers Expertise on New Lung Cancer CT Screening RecommendationsMarch 12th, 2021
Practical Challenges in Patients with Stage III NSCLC Receiving Checkpoint Inhibitors After ChemoradiationFebruary 6th, 2020
Join now to see all